![System.Func`1[System.String]](/siteassets/images/z-mckesson-logosicons/health-systems2.png)
Our Specialty Pharmacy Enablement (SPE) expert discusses 3 critical areas of access for the health system specialty pharmacy.
Could Expanding the CGT Network to Include Community Hospitals Ease Capacity Constraints and Improve Patient Access?
As the CGT pipeline grows, the currently CGT delivery model may feel the strain.
By
Date
May 22, 2024
Read time: 4 minutes
By: Joe DePinto
In a recent article published by Cell & Gene and coauthored by Joe DePinto, Head of Cell, Gene, & Advanced Therapies at McKesson, the challenges and future of cell and gene therapy (CGT) access in the U.S. are discussed. With 32 CGT products currently available and a growing pipeline, the healthcare system faces capacity issues. This insightful piece explores the possibility of expanding the healthcare provider network to include community hospitals, which could potentially alleviate capacity constraints and enhance patient care for CGTs. Read the full article, Part 1: Mobilizing Community Hospitals To Improve Patient Access To Cell And Gene Therapies, on Cell & Gene.
Subscribe Now
To learn how McKesson can help health systems achieve more, sign up to have the Prescribed Perspectives newsletter delivered directly to your inbox.
Related Stories
The most downloaded content by health system pharmacy leaders in August 2025.
With available labor resources dwindling and a shrinking pipeline, health systems must find creative solutions for better using the personnel and partnerships they have.
As payer dynamics shift, therapy pipelines grow, and leakage accelerates, health systems leaders should rethink what infusion care can and should be.
At this year's event, our experts heard from health systems who may be underutilizing available tools and resources in 340B program management.
Click through this interactive experience for a closer look at what you can expect at this year’s HealthTrust University Conference.
Our experts continue shaping industry conversations through regular conference and event engagements, like the HealthTrust University 340B Summit.
The most downloaded content by health system pharmacy leaders in July 2025.
McKesson’s Head of Cell, Gene, and Advanced Therapies discusses opportunities and challenges with CGT in the health system.
This interactive experience highlights key aspects of our SPE solutions, designed to help your health system achieve more.